Amphastar Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Rancho Cucamonga, CA
AMPH chart
What traders are saying about $AMPH
Latest postsAmphastar Pharmaceuticals, Inc. news
- 'ACE Eli Lilly Value Chain' Ranks No. 1 in Six-Month Returns Among Passive Healthcare ETFs
아시아경제 ·
- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock Now Rated "Reduce" by Wall Street Analysts
MarketBeat ·
- Amphastar Pharmaceuticals (NASDAQ:AMPH) Rating Lowered to Buy at Wall Street Zen
MarketBeat ·
- Amphastar Pharmaceuticals, Inc. Estimates – NASDAQ:AMPH
TradingView ·
- Amphastar Pharmaceuticals, Inc. (AMPH) Stock Forecasts
Yahoo Finance ·
- Amphastar Pharmaceuticals (NASDAQ:AMPH) Share Price Breaks Above 50-Day Moving Average - What's Next?
MarketBeat ·
- A Look Back at Generic Pharmaceuticals Stocks’ Q2 Earnings: Viatris (NASDAQ:VTRS) Vs The Rest Of The Pack
The Globe and Mail ·
- Amphastar Pharmaceuticals (AMPH) Stock Looks About Right After A 42% Slide
Yahoo Finance ·
- 1 Safe-and-Steady Stock to Research Further and 2 Facing Challenges
Yahoo Finance ·
- Should Value Investors Buy Amphastar Pharmaceuticals (AMPH) Stock?
Yahoo Finance ·
- 3 Stocks Under $50 We Think Twice About
Yahoo Finance ·
- 3 Reasons to Avoid AMPH and 1 Stock to Buy Instead
Yahoo Finance ·
Amphastar Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $719.9M | $732.0M | $644.4M | $499.0M |
| Net income | $98.1M | $159.5M | $137.5M | $91.4M |
| Diluted EPS | $2.03 | $3.06 | $2.60 | $1.74 |
| Total assets (year end) | $1.63B | $1.58B | $1.51B | $742.0M |
| Cash and equivalents (year end) | $170.2M | $151.6M | $144.3M | $156.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Amphastar Pharmaceuticals, Inc.
- Ticker
- AMPH (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Rancho Cucamonga, CA
- Fiscal year end
- December 31
- SEC CIK
- 1297184
Frequently asked questions
What exchange is Amphastar Pharmaceuticals, Inc. listed on?
Amphastar Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol AMPH.
What industry is Amphastar Pharmaceuticals, Inc. in?
Amphastar Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Amphastar Pharmaceuticals, Inc. headquartered?
Amphastar Pharmaceuticals, Inc.'s business address on file with the SEC is in Rancho Cucamonga, CA.
When does Amphastar Pharmaceuticals, Inc.'s fiscal year end?
Amphastar Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Amphastar Pharmaceuticals, Inc. report?
Amphastar Pharmaceuticals, Inc. reported $719.9M in revenue for calendar year 2025, according to its SEC filings.